Clinical trial
Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix…
NCT00197249 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00197249 |
|---|---|
| Title | Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity |
| Official title | A Phase III, Open, Randomized, Multicentric Study to Compare the Reactogenicity and Immunogenicity of GSK Biologicals' Combined Vi Polysaccharide Typhoid Vaccine and Inactivated Hepatitis A Vaccine, to That Elicited by GSK Biologicals' Hepatitis A Vaccine, Administered Singly or Concomitantly With… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis A |
| Intervention type | Biological |
| Interventions | Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix |
| Enrollment | 1,034 |
| Start date | May 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Nov 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 9, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: